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http:WHAT THIS PAPER ADDS
This study is the ﬁrst to evaluate EVAR performed with the combination of a low proﬁle endograft main body
and limbs constructed with a continuous spiral stent, both designed to accommodate patients with challenging
iliac anatomies.Aim: to evaluate the outcomes of EVAR performed with a new generation of bifurcated endografts and limbs.
Methods: prospectively collected data from ﬁfty consecutive patients with abdominal aortic aneurysms (AAA)
treated at our institution with a Low Proﬁle Zenith bifurcated body/Zenith Spiral-Z legs combo were analysed.
AngioCT scans and Ultrasound exams were performed prior to discharge. Ultrasound examination was repeated 6
months after the procedure to assess endograft patency and to depict endoleaks
Results: Median age was 70.6 years [50e88] and median ASA score was 3 [2e4]. Median aortic diameter was
56 mm [49e81]. Of the 100 external iliac access vessels, 14 had a diameter of 6 mm or lower. All endografts were
successfully implanted. Post-operative Ultrasound examination and angioCT scan depicted both 1 type Ia, and 10
and 19 type 2 endoleaks respectively. An asymptomatic thrombosis of the left external iliac artery distal to the
endograft limb was also depicted. 30-day mortality rate was 0%. Two patients died respectively three and four
months after EVAR. Both deaths were not aneurysm related. All patients underwent an ultrasound exam 6e12
months after EVAR. All endografts main bodies and limbs were patent. Five endoleaks were depicted, all were
type II endoleaks (the early type Ia endoleak had sealed spontaneously; it was conﬁrmed by an angioCT scan).
One patient presented a signiﬁcant stenosis of the left iliac limb at the level of a narrow and calciﬁed aortic
bifurcation. It was successfully treated by bilateral iliac angioplasty and kissing balloon stenting.
Conclusions: EVAR performed with the Zenith LP main body in combination with Spiral-Z Iliac Legs is safe and
effective. No limb occlusions were diagnosed at the 6 month follow up even in challenging iliac anatomies usually
considered as contra indications for EVAR. Our ﬁrst results are most satisfying and calling to be completed by
a longer follow up.
 2013 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Since the ﬁrst endovascular repair of an infrarenal abdominal
aortic aneurysm (EVAR) published by Parodi et al.,1 endog-
rafts have undergone continuous improvement. A decade
ago, the various EVAR components required 18 to 24 Fr
delivery systems, and 21 to 28 Fr for TEVAR - limiting
treatment to patients with large vascular access vessels
(at least 7 mm diameter) or requiring use of vascular
conduits. According to the 2000 EUROSTAR report,2 most
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//dx.doi.org/10.1016/j.ejvs.2013.03.022To overcome these issues, manufacturers have developed
lower proﬁle delivery systems. Sheath sizes as low as 14e16
Fr allow treatment of patients with challenging access. It is
also expected that these patients with challenging access and
narrow, calciﬁed tortuous iliac arteries will have higher rates
of iliac complications such as limb occlusions, limb stenosis,
and limb kinking. To address these issues a new generation of
iliac limbs is also now available. Their design is intended to
conform better to kinked and narrow iliac arteries. Cook
Medical almost simultaneously released on the European
market a new low proﬁle endograft (Zenith LP) and a new
iliac limb (Zenith Spiral-Z). Although not speciﬁcally indicated
to be used together (the Spiral-Z iliac limb is indicated for
uses with the Zenith Flex AAA), these Spiral-Z limb connects
to the Zenith LP main body with 2 mm of oversizing.
Moreover, the maximum sheath size for the Zenith LP and
the Spiral-Z leg are both 16 Fr. As such this combination of
devices provides a low proﬁle system for patients with
30 European Journal of Vascular and Endovascular Surgery Volume 46 Issue 1 July/2013difﬁcult access. Based on independent results with the Zenith
LP bifurcated graft and the Zenith Spiral-Z legs, we hypoth-
esized the combination would provide an optimal combina-
tion for EVAR. To test this hypothesis, our center started use
of this combination of devices at the beginning of 2012. This
paper presents the outcomes of the ﬁrst ﬁfty consecutive
patients with a minimum 6-month follow-up.
MATERIAL AND METHODS
Study design and patient selection
Our study analysed the ﬁrst ﬁfty consecutive patients with
abdominal aortic aneurysms or aortoiliac aneurysms treated
at our institution with a Low Proﬁle Zenith (Cook medical,
Bloomington, Ind, USA) bifurcated body in combination
with Zenith Spiral-Z legs (Cook medical) (Fig. 1).
All data are reported according to the reporting stan-
dards for AAA endovascular repair.3 Surgical data analysed
the approach technique (upon surgeon’s preference, open
approach or percutaneous femoral puncture in combination
with the Proglide or Prostar closure systems, (Abbott,
Menlo Park, Calif, USA), the side of introduction of the
bifurcated body, and the need for an additional procedure.
Post-operative data (performed before discharge)
compiled the Doppler analysis of the iliac and femoral axis,
and the CT scan analysis (contrast enhanced if the GFR
was>40 ml/min).
Preoperative plan
All patients underwent a preoperative angioCT scan, except
one whose renal function contraindicated iodinatedFigure 1. 3D Volume rendering reconstruction of the preoperative (a
proximal neck, angulated iliac arteries, and narrow and calciﬁed aortic
this difﬁcult anatomy.contrast medium injection, and who therefore underwent
an MR angiography. Preoperative sizing was done on
a center line reconstruction of the preoperative CT scan
using Aquarius software (TeraRecon, Focter City, CA, USA).
The following anatomical data were analysed: diameter and
length of the proximal neck, maximum aneurysm diameter,
diameter and calciﬁcation of the aorto-iliac bifurcation, and
diameter and calciﬁcation of the common and external iliac
arteries. External and common iliac arteries were consid-
ered calciﬁed when a calciﬁed stenosis of at least 30% and
a minimum 1 cm length was depicted.Endovascular procedure
All procedures were performed under general anaesthesia
in an operating theatre using a motorized image intensiﬁer
(GE-OEC 9900, GE Medical Systems, Milwaukee, Wis, USA)
in half-dose and pulse mode. We performed twenty-eight
conventional open bilateral surgical approaches, and
twenty-two bilateral percutaneous approaches with the
Proglide or Prostar closing systems (Abbott). The EVAR
procedures were performed following the instructions for
use from the manufacturer (with the exception of a sheath
exchange for the ipsilateral limb deployment).Endografts characteristics
Zenith LP main body(cook medical). According to the
manufacturer, the Zenith Low Proﬁle AAA Endovascular
Graft bifurcated aortic main body (ZALB) is constructed of
woven polyester fabric sewn to self-expanding nitinol stents
with braided polyester and monoﬁlament polypropylene) and discharge (b) angioCT scans of an AAA with a challenging
bifurcation. The bifurcated body and the iliac limbs adapted well to
G. Couchet et al. 31suture. The body is fully stented. The bare suprarenal stent
at the proximal end of the graft contains barbs for addi-
tional ﬁxation of the device. The inner diameter of its
integrated delivery sheath is 16Fr.
Zenith Spiral-Z Iliac Legs (Cook medical). The Zenith Spiral-
Z AAA Iliac Legs (ZSLE) are constructed of full-thickness
woven polyester fabric sewn to two self-expanding stain-
less steel Cook-Z stents and a continuous nitinol spiral
stent with braided polyester and monoﬁlament poly-
propylene suture. The graft is also fully stented. The inner
diameter of its delivery system is either 14Fr (16 mm and
lower distal iliac leg diameter) or 16 Fr depending on the
graft diameter.
Data analysed
Both clinical and technical successes were analysed. Tech-
nical success was deﬁned as prosthesis implantation
without surgical conversion, patient death nor type I or III
endoleaks at 24 h. Clinical success was deﬁned as absence
of morbidity and mortality during the perioperative and
postoperative period up to 30 days after surgery.
Major and minor adverse events were recorded, as well
as all causes of death. Major adverse events were deﬁned
as myocardial infarction, post-operative decompensated
renal failure, and acute respiratory failure requiring either
assisted mechanical ventilation for more than 72 h, or
reintubation. Decompensated renal failure was deﬁned as
a clearance decline of over 10% or over 20 mL.min-1
compared to preoperative clearance. Minor adverse events
were presence of a pseudoaneurysm, of a femoral stenosis
or a lymphocele, dissection of iliofemoral arteries or cuta-
neous infection.
Follow up
In addition to the aforementioned postoperative exams,
a new ultrasound examination of the aorta and the iliofe-
moral axis was performed six months after the endograft
implantation.
RESULTS
Demographic data
Our retrospective study of prospectively collected data ana-
lysed the outcomes of ﬁfty patients (forty-nine men), with
a median age of 70.6 years [50e88] and a median ASA score
of 3 [2e4], treated between January and June 2012. During
the study period, 67 additional patients with an AAA were
treated at our institution: 44 by open surgery, 2 with an
aorto uni iliac endograft, and 21 with a fenestrated device.
Morphologic data
Among the ﬁfty patients treated, forty-six had an aortic or
aortoiliac aneurysm (including two false aneurysms), and
four isolated common iliac aneurysms. Median aortic
diameter was 56 mm [49e81] for the aortic or aortoiliac
aneurysms, and median iliac diameter was 39 mm [32e48]for the isolated iliac aneurysms. Median proximal neck
diameter was 23.3 mm [17e29 mm] and median proximal
neck length was 27.7 mm [12e38].
The median common iliac arteries diameter in patients
with isolated aortic aneurysms was 12.4 mm [8e48 mm] on
the right side and 13.7 mm [7e43 mm] on the left side.
Twenty common iliac arteries were calciﬁed (40%). External
iliac arteries had a median diameter of 9.2 mm [5e17 mm];
25 were calciﬁed (50%). Of the 100 external iliac access
vessels, 14 had a diameter of 6 mm or lower.
Procedures
Five different operators performed the ﬁfty procedures.
One patient was treated emergently upon detection of
a tender 75 mm diameter AAA. Implantation under full
anticoagulation established using sodium heparin (50 units/
kg) of the main body and both iliac limbs was successfully
performed in all cases. The main body was introduced
through the right common femoral artery in 36 cases. No
iliac conduits were required.
Five additional procedures were planned and performed:
3 embolizations of the origin of the internal iliac artery
trunk and 2 angioplasty-stenting (one kissing bilateral
common iliac angioplasty-stenting in a patient with an
18 mm calciﬁed aortic bifurcation, and one angioplasty/
stenting of a limb in a kinked iliac artery).
A left inferior polar renal artery (2.5 mm diameter) was
deliberately covered to achieve a proximal seal (it was not
associated with post-operative renal impairment). No
unexpected coverage of a renal artery or an intern iliac
artery occurred. Median contrast media volume and oper-
ation time were 72 ml (30e160 ml) and 83 min (44e
130 min) respectively.
The only peroperative complication depicted was
a percutaneous closure system failure (incomplete haemo-
stasis requiring open femoral artery repair), which occurred
twice on 46 percutaneous approaches (4.3%). These failures
were not associated with small calibre access vessels (9 mm
diameter in both cases) or calciﬁcations.
Post-operative period
Median hospital stay was 8.1 days [5e26]. All patients had
post-operative antiplatelet therapy. Before discharge, 47 of
the 50 patients underwent ultrasound examination of the
aorta and the ilioefemoral axis. A postoperative angioCT
scan was performed in 46 patients. The remaining 4
patients had a CT scan with no contrast medium injection
because of an altered renal function. No patients required
dialysis following EVAR.
Ultrasound examination depicted 11 endoleaks: 1 type I,
10 type II and no types III or IV. The type I endoleak was
proximal, considered of very limited volume; no additional
treatment was scheduled at his stage.
The ultrasound controls of femoral access sites identiﬁed:
5 hematomas, 2 pseudoaneurysms, 5 dissections, 2 stenosis,
1 lymphocele and 1 thrombosis of the left external iliac
artery (distal to the endograft limb). All were asymptomatic
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compression was performed to occlude the 2 pseudoa-
neurysms). The external iliac thrombosis was asymptomatic
and required no further treatment; it was probably due to
the small calibre of this vessel (6 mm diameter).
AngioCTscan analysis depicted 20 endoleaks: one prox-
imal type I, 19 type II, and no type III or IV.Six-month follow up
The survival rate at six months was 96%. Two patients died
respectively three and four months after EVAR (cardiac
failure and pneumonia). Both deaths were not aneurysm
related.
All patients underwent an aorto-iliac control ultrasound
exam 6e12 months after EVAR. All endografts main bodies
and limbs were patent. Five endoleaks were depicted, all
were type II endoleaks (the early type Ia endoleak had
sealed spontaneously; it was conﬁrmed by an angioCT scan).
One additional femoral pseudoaneurysm was diagnosed
(currently undergoing ultrasound surveillance).
During follow-up, one patient presented six months after
discharge with disabling claudication of the lower limbs.
Ultrasonography showed a patent endograft and an excluded
aneurysm; however, there was a signiﬁcant stenosis of the
left iliac limb. A new analysis of the preoperative images
found a narrow (18 mm) and calciﬁed aortic bifurcation. A
complementary procedure (bilateral iliac angioplasty and
kissing balloon stenting of the iliac limbs with balloon
expandable 10 mm stents) was thus performed 7 months
after the initial surgery. Postoperative Doppler control
showed good morphologic and haemodynamic results and
the initial symptoms had resolved at discharge.
DISCUSSION
Early experience with the Spiral-Z iliac limb in association
with the LP body has shown very favourable outcomes,
even in patients with challenging iliac anatomies. No
procedure required a retroperitoneal approach or a conduit
to enable vascular access. While the smallest iliac diameter
in our series was 5 mm, fourteen vascular accesses were
classiﬁed as difﬁcult because of a vessel diameter of 6 mm
or less. These 14 accesses entailed neither major peri-
operative complication nor necessity for conversion.
Although we noted dissection and stenosis on these small
calibre vessels, these complications have also been reported
for superior calibre vessels in the literature.4,5
In 2000, Cuypers and al2 reported access difﬁculties for
13% of all endovascular procedures in the EUROSTAR
Registry. More speciﬁcally, 28.6% of the 49 conversion cases
were a result of failure to introduce or injury from intro-
duction of the bifurcated main body, historically the largest
proﬁle component of the system. However, the EVAR
delivery systems used were of a larger diameter (20Fr and
above) than those used in our study (16Fr inner diameter).
Carpenter and al6 showed that one of the risk factors for
contraindication to endovascular procedures was small
vascular access and particularly external iliac arteries under7 mm in diameter, thus unable to bear 18 Fr sheaths.
According to them, only 70% of males and 44% of females
were eligible for an endovascular procedure; of the
excluded patients, 47% (both genders) were ineligible
because of an unfavourable iliac anatomy. 16 Fr Low Proﬁle
EVAR was not available in 2000, their evaluation would
probably be different nowadays.7,8 Had we limited
ourselves, in our study, to extern iliac axis greater than
7 mm, eleven patients (>20%) out of ﬁfty wouldn’t have
been candidates for an EVAR procedure. Eight of them
would have been eligible for an aorto-uniiliac endograft
requiring a cross over femoral bypass.
Treating patients with small calibre vascular access could
cause, on the long term, more limb occlusions and throm-
bosis, according to Carroccio et al.9 In these challenging
cases angioplasty-stenting following EVAR has been rec-
ommended.10,11 The effectiveness of angioplasty stenting to
reduce limb occlusions was demonstrated by Sivamurthy
et al.12 They reported a 0% incidence of graft limb occlusion
through 3 years in patients treated with adjunctive stent
placement at the time of the procedure as compared to
a 7.1% (13/184) rate of limb occlusion in patients without
adjunctive stent placement. In our study, angioplasty was
required in 2 patients during the index procedure and in
one patient during follow-up to maintain all limbs patent.
Often extension of the limbs into the external iliacs is
required to insure a good seal. However landing the
endograft distally in the smaller diameter external iliac
increases the thrombosis risk.9 In our study, there were no
limb occlusions when the Spiral Z limbs were implanted in
the external iliacs (3 cases).
Several manufacturers have developed Low Proﬁle EVAR
systems. Medtronic’s Endurant (Medtronic, Santa Rosa, Calif,
USA) endograft is loaded an 18e20 Fr delivery system (outer
diameter). The various series evaluating this endograft4,5,13,14
report a satisfying technical success rate even in difﬁcult
anatomies. They all report difﬁculties or complications due to
small calibre accesses, such as iliac artery dissections,
conversion for iliac artery rupture, or launching failure. Rou-
wet and al described two claudication-inducing iliac artery
dissections, one limb thrombosis before discharge, one limb
occlusion at 30 days and three after a year.4 Stokmans and al5
reported 23 limb occlusions and 16 limb stenosis out of 1262
patients treated. Torsello and al,14 in their 45-cases series,
described 5 iliac limb stenosis that required iliac stenting.
Follow-up showed, at one month, a limb thrombosis
successfully treated by thrombectomy and angioplasty-
stenting - a successful procedure with 12-month perme-
ability. Our 50-case series found no limbocclusions at 6-month
follow up, but documented one stenosis requiring angioplasty-
stenting, and one post-operative external iliac thrombosis
beyond the limb. This limb remained patent at six months.CONCLUSION
Our series is the ﬁrst to describe results of the Zenith LP
main body in combination with Spiral-Z Iliac Legs. No major
complications were depicted. Speciﬁcally there was a 0%
G. Couchet et al. 33rate of limb occlusions noted at the 6 month follow up. One
external iliac artery occlusion was diagnosed below a patent
iliac limb and one limb stenosis required a secondary
procedure. Our ﬁrst results are most satisfying in this cohort
of patients some of whom had challenging anatomy and
calling to be completed by a longer follow up.
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